Patient Screening to Resume in IntelGenx’s ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease
October 12, 2021 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Oct. 12, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx” or the “Company”)), a leader in pharmaceutical films, today announced its intention to...
IntelGenx Receives Final Approval to Graduate to Toronto Stock Exchange
October 05, 2021 14:15 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Oct. 05, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (“IntelGenx” or ”the “Company”) announces that it has received final approval to...
IntelGenx and Aquestive Therapeutics Partner with Leading Men’s Health Company to Market Tadalafil Oral Films in the U.S.
September 29, 2021 16:30 ET
|
IntelGenx Technologies Corp. ; Aquestive Therapeutics, Inc.
SAINT LAURENT, Quebec, Sept. 29, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSXV:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that its co-development and commercialization partner for Tadalafil...
IntelGenx Receives U.S.$6 Million in Additional Loans from atai Life Sciences and Conditional Approval to Graduate to Toronto Stock Exchange
September 15, 2021 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Sept. 15, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (the “Company”) announces that its wholly-owned subsidiary, IntelGenx Corp....
IntelGenx Announces Market Launch of RIZAPORT® in Spain
September 07, 2021 16:15 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Sept. 07, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that Exeltis Healthcare S.L. (“Exeltis”), its...
IntelGenx Ships CBD Filmstrips to Heritage Cannabis in Support of Canadian Market Launch
August 31, 2021 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Aug. 31, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it has completed an initial shipment of CBD...
IntelGenx Announces Closing of Notes Offering
August 05, 2021 10:30 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Aug. 05, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (the “Company” or “IntelGenx”) announces the closing of an offering by way of private...
IntelGenx Reports Second Quarter 2021 Financial Results
August 04, 2021 16:03 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Aug. 04, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the second quarter...
IntelGenx Strengthens Board with the Appointments of Dr. Srinivas G. Rao and Frank Stegert
August 04, 2021 09:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Aug. 04, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced the appointments of Srinivas (Srini) G....
IntelGenX to Report Second Quarter 2021 Financial Results on August 4, 2021 – Conference Call to Follow
July 29, 2021 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, July 29, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that it will release its second quarter 2021 financial...